tiprankstipranks
Trending News
More News >
GlucoTrack (GCTK)
NASDAQ:GCTK
US Market
Advertisement

GlucoTrack (GCTK) Technical Analysis

Compare
236 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
3Neutral
6Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
GlucoTrack’s (GCTK) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting GlucoTrack is a Sell.
GlucoTrack’s (GCTK) 20-Day exponential moving average is 5.56, while GlucoTrack’s (GCTK) share price is $10.59, making it a Buy.
GlucoTrack’s (GCTK) 50-Day exponential moving average is 7.13, while GlucoTrack’s (GCTK) share price is $10.59, making it a Buy.

GlucoTrack (GCTK) Pivot Points

Sep 15, 2025, 04:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.10
4.33
4.60
4.83
5.10
5.33
5.60
Fibonacci
4.33
4.52
4.64
4.83
5.02
5.14
5.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlucoTrack (GCTK) Moving Averages

Sep 15, 2025, 04:19 PM
Period
Simple
Exponential
MA5
5.86Buy
6.70Buy
MA10
5.37Buy
5.85Buy
MA20
5.24Buy
5.56Buy
MA50
5.85Buy
7.13Buy
MA100
7.07Buy
67.37Sell
MA200
65.72Sell
371.07Sell
GlucoTrack’s (GCTK) 10-Day exponential moving average is 5.85, while GlucoTrack’s (GCTK) share price is $10.59, making it a Buy.
GlucoTrack’s (GCTK) 100-Day exponential moving average is 67.37, while GlucoTrack’s (GCTK) share price is $10.59, making it a Sell.
GlucoTrack’s (GCTK) stock price is $10.59 and GlucoTrack’s (GCTK) 50-day simple moving average is 5.85, creating a Buy signal.
GlucoTrack’s (GCTK) stock price is $10.59 and GlucoTrack’s (GCTK) 100-day simple moving average is 7.07, creating a Buy signal.
GlucoTrack’s (GCTK) stock price is $10.59 and GlucoTrack’s (GCTK) 200-day simple moving average is 65.72, creating a Sell signal.

GlucoTrack (GCTK) Technical Indicators

Sep 15, 2025, 04:19 PM
Name
Value
Implied Action
RSI (14)
79.85
Sell
STOCH (9,6)
42.57
Neutral
STOCHRSI (14)
42.70
Neutral
MACD (12,26)
0.14
Sell
ADX (14)
18.84
Buy
Williams %R
-35.79
Buy
CCI (14)
514.57
Sell
ATR (14)
1.13
-
Ultimate Oscillator
55.82
Neutral
ROC
91.50
Buy
GlucoTrack’s (GCTK) Relative Strength Index (RSI) is 79.85, creating a Sell signal.
GlucoTrack’s (GCTK) Trend Strength Indicator (ADX) is 18.84, creating a Buy signal.
GlucoTrack’s (GCTK) Commodity Channel Index (CCI) is 514.57, creating a Sell signal.
GlucoTrack’s (GCTK) Price Rate of Change (ROC) is 91.50, creating a Buy signal.

FAQ

Is GCTK a Buy, Hold, or Sell?
Based on GCTK’s technical indicators, GCTK is a Buy.
    What is GCTK’s RSI (14)?
    GCTK’s RSI (14) is 79.85, which suggests GCTK is a Sell.
      What is GCTK’s MACD?
      GCTK’s MACD is 0.14, which suggests GCTK is a Sell.
        What is GCTK’s 5-day moving average?
        GCTK’s 5-day moving average is 5.86, which suggests GCTK is a Buy.
          What is GCTK’s 20-day moving average?
          GCTK 20-day moving average is 5.24, which suggests GCTK is a Buy.
            What is GCTK’s 50-day moving average?
            GCTK’s 50-day moving average is 5.85, which suggests GCTK is a Buy.
              What is GCTK’s 200-day moving average?
              GCTK’s 200-day moving average is 65.72, which suggests GCTK is a Sell.
                What is GCTK’s Williams % R (14)?
                GCTK’s Williams % R (14) is -35.79, which suggests GCTK is a Buy.
                  What is GCTK’s CCI (14)?
                  GCTK’s CCI (14) is 514.57, which suggests GCTK is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis